Skip to Content
Merck
  • [The effects of bromazepam on the performance of a sensory-motor activity: an electroencephalographic study].

[The effects of bromazepam on the performance of a sensory-motor activity: an electroencephalographic study].

Revista de neurologia (2009-09-04)
D Machado, V H Bastos, M Cunha, B Velasques, S Machado, L Basile, M Cagy, R Piedade, P Ribeiro
ABSTRACT

To investigate the effects of using bromazepam on the relative power in alpha while performing a typing task. Bearing in mind the particularities of each brain hemisphere, our hypothesis was that measuring the relative power would allow us to investigate the effects of bromazepam on specific areas of the cortex. More specifically, we expected to observe different patterns of powers in sensory-motor integration, attention and activation processes. The sample was made up of 39 subjects (15 males and 24 females) with a mean age of 30 +/- 10 years. The control (placebo) and experimental (3 mg and 6 mg of bromazepam) groups were trained in the typing task with a randomised double-blind model. A three-way ANOVA and Scheffé test were used to analyse interactions between the factors condition and moment, and between condition and sector. The doses used in this study facilitated motor performance of the typing task. In this study, the use of the drug did not prevent learning of the task, but it did appear to concentrate mental effort on more restricted and specific aspects of typing. It also seemed to influence the rhythm and effectiveness of the operations performed during mechanisms related to the encoding and storage of new information. Likewise, a predominance of activity was observed in the left (dominant) frontal area in the 3 mg bromazepam group, which indicates that this dose of the drug affords the subject a greater degree of directionality of cortical activity for planning and performing the task.

MATERIALS
Product Number
Brand
Product Description

Bromazepam, European Pharmacopoeia (EP) Reference Standard
Supelco
Bromazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®